Periactin and Qvar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Periactin (cyproheptadine hydrochloride) and Qvar (beclomethasone dipropionate). Common drug interactions include headache among females and septic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Periactin and Qvar. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Periactin?

Periactin has active ingredients of cyproheptadine hydrochloride. It is often used in migraine. eHealthMe is studying from 2,214 Periactin users. Check the latest studies of Periactin.

What is Qvar?

Qvar has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 17,355 Qvar users. Check the latest studies of Qvar.



On Jul, 16, 2026

28 people who take Periactin and Qvar together, and have interactions are studied.

Periactin and Qvar drug interactions.

What are the common drug interactions of Periactin and Qvar, by gender? *:

female:

  1. Headache (pain in head)
  2. Attention deficit/hyperactivity disorder
  3. Decreased appetite
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Constipation
  6. Cough
  7. Diarrhoea
  8. Dysmenorrhoea (painful menstruation)
  9. Insulin-like growth factor increased
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Septic shock (shock due to blood infection)
  2. Vomiting
  3. Cough
  4. Discomfort
  5. Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
  6. Dizziness
  7. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  8. Dysarthria (speech disorder)
  9. Dystonia (abnormal muscle tone)
  10. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)

What are the common drug interactions of Periactin and Qvar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Septic shock (shock due to blood infection)
  4. Constipation
  5. Vomiting
  6. Attention deficit/hyperactivity disorder
  7. Decreased appetite
  8. Dysmenorrhoea (painful menstruation)
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  10. Insulin-like growth factor increased

10-19:

  1. Pyrexia (fever)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Pneumonia
  4. Cough
  5. Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
  6. Faecaloma (hard mass of fecal matter)
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Lung disorder (lung disease)
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Respiratory disorder (respiratory disease)

20-29:

n/a

30-39:

n/a

40-49:

  1. Laryngitis (inflammation of the larynx)
  2. Drug hypersensitivity
  3. Impaired work ability

50-59:

n/a

60+:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Dizziness
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Pneumonia
  5. Pyrexia (fever)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Type 2 diabetes mellitus
  8. Vomiting

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 12 people, 42.86%
  2. Pain: 4 people, 14.29%
  3. Malaise (a feeling of general discomfort or uneasiness): 4 people, 14.29%
  4. Hypersensitivity: 4 people, 14.29%
  5. Growth Hormone Deficiency: 4 people, 14.29%
  6. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 14.29%
  7. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 10.71%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
  9. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 3 people, 10.71%
  10. Lung Disorder (lung disease): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Periactin and Qvar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Periactin and Qvar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Periactin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Qvar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Periactin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Qvar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyproheptadine hydrochloride and beclomethasone dipropionate (the active ingredients of Periactin and Qvar, respectively), and Periactin and Qvar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: